For instance, members of the EGFR family of receptors, like HER2, are overexpressed in a sizable portion of breast cancer patients and activate several signalling pathways that promote tumour development and metastasis (Hynes and Lane, 2005). The gene discussed is ERBB2; the disease is breast cancer.